Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-04-15

FDA Approved: PREGNYL — Supplemental Application (Organon LLC)

View source ↗

Summary

The FDA approved a supplemental application for PREGNYL (chorionic gonadotropin alfa) from Organon LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PREGNYL (Chorionic gonadotropin alfa)

Snippet

SUPPL AP for PREGNYL (CHORIOGONADOTROPIN ALFA)